These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38234231)

  • 1. Metabolic and other morbid complications in congenital generalized lipodystrophy type 4.
    Akinci G; Alyaarubi S; Patni N; Alhashmi N; Al-Shidhani A; Prodam F; Gagne N; Babalola F; Al Senani A; Muniraj K; Elsayed SM; Beghini M; Saydam BO; Allawati M; Vaishnav MS; Can E; Simsir IY; Sorkina E; Dursun F; Kamrath C; Cavdar U; Chakraborty PP; Dogan OA; Al Hosin A; Al Maimani A; Comunoglu N; Hamed A; Huseinbegovic T; Scherer T; Curtis J; Brown RJ; Topaloglu H; Simha V; Wabitsch M; Tuysuz B; Oral EA; Akinci B; Garg A
    Am J Med Genet A; 2024 Jun; 194(6):e63533. PubMed ID: 38234231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations.
    Shastry S; Delgado MR; Dirik E; Turkmen M; Agarwal AK; Garg A
    Am J Med Genet A; 2010 Sep; 152A(9):2245-53. PubMed ID: 20684003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital generalized lipodystrophy: The evaluation of clinical follow-up findings in a series of five patients with type 1 and two patients with type 4.
    Nilay Güneş ; Kutlu T; Tekant GT; Eroğlu AG; Üstündağ NÇ; Öztürk B; Onay H; Tüysüz B
    Eur J Med Genet; 2020 Apr; 63(4):103819. PubMed ID: 31778856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital generalized lipodystrophy type 4 due to a novel PTRF/CAVIN1 pathogenic variant in a child: effects of metreleptin substitution.
    Adiyaman SC; V Schnurbein J; De Laffolie J; Hahn A; Siebert R; Wabitsch M; Kamrath C
    J Pediatr Endocrinol Metab; 2022 Jul; 35(7):946-952. PubMed ID: 35405042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of severe hypertriglyceridemia with icosapent ethyl in a case of congenital generalized lipodystrophy type 4.
    Babalola F; Ng D; Bulic A; Curtis J
    J Pediatr Endocrinol Metab; 2022 Jul; 35(7):968-972. PubMed ID: 35417107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmortem Findings in a Young Man With Congenital Generalized Lipodystrophy, Type 4 Due to CAVIN1 Mutations.
    Patni N; Vuitch F; Garg A
    J Clin Endocrinol Metab; 2019 Mar; 104(3):957-960. PubMed ID: 30476128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of clinical manifestations in two young Turkish patients with congenital generalized lipodystrophy type 4.
    Akinci G; Topaloglu H; Akinci B; Onay H; Karadeniz C; Ergul Y; Demir T; Ozcan EE; Altay C; Atik T; Garg A
    Eur J Med Genet; 2016 Jun; 59(6-7):320-4. PubMed ID: 27167729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations.
    Rajab A; Straub V; McCann LJ; Seelow D; Varon R; Barresi R; Schulze A; Lucke B; Lützkendorf S; Karbasiyan M; Bachmann S; Spuler S; Schuelke M
    PLoS Genet; 2010 Mar; 6(3):e1000874. PubMed ID: 20300641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel PTRF mutation in a child with mild myopathy and very mild congenital lipodystrophy.
    Ardissone A; Bragato C; Caffi L; Blasevich F; Maestrini S; Bianchi ML; Morandi L; Moroni I; Mora M
    BMC Med Genet; 2013 Sep; 14():89. PubMed ID: 24024685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new mutation in the
    Mancioppi V; Daffara T; Romanisio M; Ceccarini G; Pelosini C; Santini F; Bellone S; Mellone S; Baricich A; Rabbone I; Aimaretti G; Akinci B; Giordano M; Prodam F
    Front Endocrinol (Lausanne); 2023; 14():1212729. PubMed ID: 37501786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural History of Congenital Generalized Lipodystrophy: A Nationwide Study From Turkey.
    Akinci B; Onay H; Demir T; Ozen S; Kayserili H; Akinci G; Nur B; Tuysuz B; Nuri Ozbek M; Gungor A; Yildirim Simsir I; Altay C; Demir L; Simsek E; Atmaca M; Topaloglu H; Bilen H; Atmaca H; Atik T; Cavdar U; Altunoglu U; Aslanger A; Mihci E; Secil M; Saygili F; Comlekci A; Garg A
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2759-67. PubMed ID: 27144933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical spectra of neuromuscular manifestations in patients with lipodystrophy: A multicenter study.
    Akinci G; Topaloglu H; Demir T; Danyeli AE; Talim B; Keskin FE; Kadioglu P; Talip E; Altay C; Yaylali GF; Bilen H; Nur B; Demir L; Onay H; Akinci B
    Neuromuscul Disord; 2017 Oct; 27(10):923-930. PubMed ID: 28754454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of disease characteristics of a large patient cohort with congenital generalized lipodystrophy from the Middle East and North Africa.
    Al Yaarubi S; Alsagheir A; Al Shidhani A; Alzelaye S; Alghazir N; Brema I; Alsaffar H; Al Dubayee M; Alshahrani A; Abdelmeguid Y; Omar OM; Attia N; Al Amiri E; Al Jubeh J; Algethami A; Alkhayyat H; Haleem A; Al Yahyaei M; Khochtali I; Babli S; Nugud A; Thalange N; Albalushi S; Hergli N; Deeb A; Alfadhel M
    Orphanet J Rare Dis; 2024 Mar; 19(1):118. PubMed ID: 38481246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Face-sparing Congenital Generalized Lipodystrophy Type 1 Associated With Nonclassical Congenital Adrenal Hyperplasia.
    Costa S; Sampaio L; Berta Sousa A; Xing C; Agarwal AK; Garg A
    J Clin Endocrinol Metab; 2022 Aug; 107(9):2433-2438. PubMed ID: 35857714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of generalized lipodystrophy in Turkey: A cohort analysis.
    Yildirim Simsir I; Tuysuz B; Ozbek MN; Tanrikulu S; Celik Guler M; Karhan AN; Denkboy Ongen Y; Gunes N; Soyaltin UE; Altay C; Nur B; Ozalkak S; Akgun Dogan O; Dursun F; Pekkolay Z; Eren MA; Usta Y; Ozisik S; Ozgen Saydam B; Adiyaman SC; Unal MC; Gungor Semiz G; Turan I; Eren E; Kayserili H; Jeru I; Vigouroux C; Atik T; Onay H; Ozen S; Arioglu Oral E; Akinci B
    Diabetes Obes Metab; 2023 Jul; 25(7):1950-1963. PubMed ID: 36946378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biallelic CAV1 null variants induce congenital generalized lipodystrophy with achalasia.
    Karhan AN; Zammouri J; Auclair M; Capel E; Apaydin FD; Ates F; Verpont MC; Magré J; Fève B; Lascols O; Usta Y; Jéru I; Vigouroux C
    Eur J Endocrinol; 2021 Nov; 185(6):841-854. PubMed ID: 34643546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I Mutation.
    Hussain I; Patni N; Ueda M; Sorkina E; Valerio CM; Cochran E; Brown RJ; Peeden J; Tikhonovich Y; Tiulpakov A; Stender SRS; Klouda E; Tayeh MK; Innis JW; Meyer A; Lal P; Godoy-Matos AF; Teles MG; Adams-Huet B; Rader DJ; Hegele RA; Oral EA; Garg A
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1005-1014. PubMed ID: 29267953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac steatosis and left ventricular hypertrophy in patients with generalized lipodystrophy as determined by magnetic resonance spectroscopy and imaging.
    Nelson MD; Victor RG; Szczepaniak EW; Simha V; Garg A; Szczepaniak LS
    Am J Cardiol; 2013 Oct; 112(7):1019-24. PubMed ID: 23800548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Difficult to manage diabetes mellitus associated with generalized congenital lipodystrophy. Report of two cases].
    Cardona-Hernández R; Suárez-Ortega L; Torres M
    An Pediatr (Barc); 2011 Feb; 74(2):126-30. PubMed ID: 21168376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinopathy and Uveitis in Congenital Generalized Lipodystrophy with Hypertriglyceridemia and Uncontrolled Diabetes (Berardinelli-Seip Syndrome).
    Rubaie KA; Raef H; Stone DU; Kozak I
    Middle East Afr J Ophthalmol; 2019; 26(4):250-252. PubMed ID: 32153340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.